AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

GLXA-directed Antibody Protects Mice From Human C. Trachomatis.(Brief Article)

Vaccine Weekly

| September 12, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 SEP 12 - (NewsRx.com & NewsRx.net) --

by N.R. Saltmarsh, staff medical writer - An anti-idiotypic monoclonal antibody vaccine against chlamydia protects mice from infectious challenge with a human urogenital strain of Chlamydia trachomatis, according to a new report in Vaccine.

The finding suggests a possible new avenue for chlamydia vaccine research, which has yielded little new information in the past three decades, said J.A. Whittum-Hudson and colleagues in the United States.

"No vaccine candidate has protected against heterologous challenge, nor at more than one site of infection," they pointed out. "The majority of experimental anti-chlamydial vaccines to date have targeted the chlamydial major outer membrane protein (MOMP). Many MOMP-directed vaccine candidates have been highly immunogenic, but have failed to protect against infectious challenge."

Whittum-Hudson and team turned their attention to a different antichlamydial vaccine, a monoclonal anti-idiotypic antibody (anti-Id; mAb2), which is a molecular mimic of the chlamydial glycolipid exoantigen (GLXA).

When C3H/HeJ mice were vaccinated with either mucosal (oral or intranasal) or systemic (subcutaneous) poly (lactide) encapsulated mAb2 to GLXA, they were significantly protected against topical vaginal challenge with C. trachomatis (K serovar; UW-31), reported Whittum-Hudson and coworkers. Reduced vaginal shedding of C. trachomatis and less genital ...

Related articles from newspapers, magazines, journals, and more
Findings from University of California broaden understanding of vaccinia virus.
Newspaper article from: Vaccine Weekly July 15, 2009 700+ words
...Santa Barbara, Enzyme Research, Kinase, Vaccinia Virus, Viral, Virology, University of California. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
Study findings from E.F. Dunne et al provide new insights into human...
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Papillomavirus, Immunization, Infectious Disease, Sexually Transmitted Disease, Vaccines, Women's Health This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
Report summarizes immunization study findings from J. Chow and co-researchers.
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Cirrhosis, Fibrosis, Immunization, Infectious Diseases, Nephrology, Renal Disease, Vaccination, Vaccines This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
Data on vaccines detailed by B. Guss and co-authors.
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Antibiotic, Antimicrobial, Biotechnology, Drug Development, Immunization, Therapy, Treatment, Vaccines This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
New autoimmune disease research reported from N. Agmonlevin and co-authors.
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Autoimmune Disorder, Biotechnology, Hypersensitivity, Immunology, Rheumatology, Therapy, Treatment, Vaccines This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
Study results from Federal University of Minas Gerais broaden understanding of...
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Keywords: City:Belo Horizonte, Country:Brazil, Biotechnology, Clostridium, Kidney Disease, Vaccines This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
Recent findings in life sciences described by S. Hilton and colleagues.
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Country:Scotland, Biotechnology, Infectious Disease, Life Sciences, Measles, Mumps, Rubella, Vaccines This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
Studies from University of Michigan, Medical Department update current data on...
Newspaper article from: Vaccine Weekly December 9, 2009 700+ words
...Mucosal Immunization, Therapy, Treatment, Urinary Tract Infection, Urology, Vaccines, Women's Health This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2009, Vaccine Weekly via NewsRx.com.
For more facts and information, see all results

Source: HighBeam Research, GLXA-directed Antibody Protects Mice From Human C. Trachomatis.(Brief...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA